{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:23:56Z","timestamp":1786987436283,"version":"build-2736575974"},"reference-count":96,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T00:00:00Z","timestamp":1720742400000},"content-version":"am","delay-in-days":346,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Pharmacology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.coph.2023.102393","type":"journal-article","created":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T19:07:21Z","timestamp":1689188841000},"page":"102393","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Adenosine signaling as target in cardiovascular pharmacology"],"prefix":"10.1016","volume":"71","author":[{"given":"Luca","family":"Antonioli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Fornai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Pellegrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e1l","family":"Pacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gy\u00f6rgy","family":"Hask\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coph.2023.102393_bib1","first-page":"1","article-title":"Cardiovascular disease as a leading cause of death: how are pharmacists getting involved?","volume":"8","author":"Mc Namara","year":"2019","journal-title":"Integrated Pharm Res Pract"},{"key":"10.1016\/j.coph.2023.102393_bib2","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1007\/s40273-020-00936-0","article-title":"Novel treatment strategies for secondary prevention of cardiovascular disease: a systematic review of cost-effectiveness","volume":"38","author":"Marquina","year":"2020","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.coph.2023.102393_bib3","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1161\/HYPERTENSIONAHA.118.10842","article-title":"Adenosine receptors: a tantalizing target for the treatment of salt-sensitive hypertension","volume":"72","author":"Denton","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.coph.2023.102393_bib4","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1517\/13543784.9.11.2519","article-title":"Adenosine therapy: a new approach to chronic heart failure","volume":"9","author":"Kitakaze","year":"2000","journal-title":"Expet Opin Invest Drugs"},{"key":"10.1016\/j.coph.2023.102393_bib5","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1007\/s11883-012-0263-y","article-title":"Regulation of atherosclerosis and associated risk factors by adenosine and adenosine receptors","volume":"14","author":"Koupenova","year":"2012","journal-title":"Curr Atherosclerosis Rep"},{"key":"10.1016\/j.coph.2023.102393_bib6","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/978-3-540-89615-9_7","article-title":"Adenosine receptors and reperfusion injury of the heart","author":"Headrick","year":"2009","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.coph.2023.102393_bib7","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0140-6736(89)91231-2","article-title":"Adenosine and hypertrophic cardiomyopathy","volume":"1","author":"Coupe","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.coph.2023.102393_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.856747","article-title":"Adenosine in acute myocardial infarction-associated reperfusion injury: does it still have a role?","volume":"13","author":"De Marco","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.coph.2023.102393_sref9","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.molmed.2013.03.005","article-title":"CD39 and CD73 in immunity and inflammation","volume":"19","author":"Antonioli","year":"2013","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.coph.2023.102393_bib10","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s40256-019-00345-5","article-title":"Adenosine and the cardiovascular system","volume":"19","author":"Reiss","year":"2019","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.coph.2023.102393_bib11","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3389\/fcvm.2019.00181","article-title":"Editorial: cardioimmunology: inflammation and immunity in cardiovascular disease","volume":"6","author":"Lazzerini","year":"2019","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.coph.2023.102393_bib12","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.imlet.2018.04.006","article-title":"Adenosine signaling and the immune system: when a lot could be too much","volume":"205","author":"Antonioli","year":"2019","journal-title":"Immunol Lett"},{"key":"10.1016\/j.coph.2023.102393_bib13","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1096\/fj.99-0508com","article-title":"Adenosine inhibits IL-12 and TNF-[alpha] production via adenosine A2a receptor-dependent and independent mechanisms","volume":"14","author":"Hasko","year":"2000","journal-title":"Faseb J"},{"key":"10.1016\/j.coph.2023.102393_bib14","doi-asserted-by":"crossref","first-page":"4634","DOI":"10.4049\/jimmunol.157.10.4634","article-title":"Adenosine receptor agonists differentially regulate IL-10, TNF-alpha, and nitric oxide production in RAW 264.7 macrophages and in endotoxemic mice","volume":"157","author":"Hasko","year":"1996","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.coph.2023.102393_bib15","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1182\/blood-2007-01-065870","article-title":"A2A adenosine receptors and C\/EBPbeta are crucially required for IL-10 production by macrophages exposed to Escherichia coli","volume":"110","author":"Csoka","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.coph.2023.102393_sref16","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1096\/fj.11-190934","article-title":"Adenosine promotes alternative macrophage activation via A2A and A2B receptors","volume":"26","author":"Csoka","year":"2012","journal-title":"Faseb J"},{"key":"10.1016\/j.coph.2023.102393_bib17","doi-asserted-by":"crossref","first-page":"4985","DOI":"10.1096\/fj.201700398R","article-title":"A2A adenosine receptors control pancreatic dysfunction in high-fat-diet-induced obesity","volume":"31","author":"Csoka","year":"2017","journal-title":"Faseb J"},{"key":"10.1016\/j.coph.2023.102393_bib18","doi-asserted-by":"crossref","first-page":"445","DOI":"10.4049\/jimmunol.1101224","article-title":"Adenosine augments IL-10 production by microglial cells through an A2B adenosine receptor-mediated process","volume":"188","author":"Koscso","year":"2012","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.coph.2023.102393_bib19","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s11302-013-9362-7","article-title":"Stimulation of A2B adenosine receptors protects against trauma-hemorrhagic shock-induced lung injury","volume":"9","author":"Koscso","year":"2013","journal-title":"Purinergic Signal"},{"key":"10.1016\/j.coph.2023.102393_bib20","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1096\/fj.07-8213com","article-title":"Adenosine receptor activation ameliorates type 1 diabetes","volume":"21","author":"Nemeth","year":"2007","journal-title":"Faseb J"},{"key":"10.1016\/j.coph.2023.102393_bib21","doi-asserted-by":"crossref","first-page":"5616","DOI":"10.4049\/jimmunol.176.9.5616","article-title":"Adenosine A2A receptor inactivation increases survival in polymicrobial sepsis","volume":"176","author":"Nemeth","year":"2006","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.coph.2023.102393_bib22","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.bbrc.2003.11.006","article-title":"Adenosine stimulates CREB activation in macrophages via a p38 MAPK-mediated mechanism","volume":"312","author":"Nemeth","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.coph.2023.102393_bib23","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1124\/jpet.103.052944","article-title":"cDNA microarray analysis reveals a nuclear factor-kappaB-independent regulation of macrophage function by adenosine","volume":"306","author":"Nemeth","year":"2003","journal-title":"J\u00a0Pharmacol Exp Therapeut"},{"key":"10.1016\/j.coph.2023.102393_bib24","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0014-2999(98)00619-0","article-title":"An agonist of adenosine A3 receptors decreases interleukin-12 and interferon-gamma production and prevents lethality in endotoxemic mice","volume":"358","author":"Hasko","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.coph.2023.102393_bib25","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1161\/ATVBAHA.111.226852","article-title":"Regulation of macrophage function by adenosine","volume":"32","author":"Hasko","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.coph.2023.102393_bib26","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/sj.bjp.0702040","article-title":"Suppression of macrophage inflammatory protein (MIP)-1alpha production and collagen-induced arthritis by adenosine receptor agonists","volume":"125","author":"Szabo","year":"1998","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.coph.2023.102393_bib27","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3389\/fimmu.2013.00085","article-title":"Regulation of inflammation by adenosine","volume":"4","author":"Hasko","year":"2013","journal-title":"Front Immunol"},{"key":"10.1016\/j.coph.2023.102393_bib28","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/nrc3613","article-title":"Immunity, inflammation and cancer: a leading role for adenosine","volume":"13","author":"Antonioli","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.coph.2023.102393_bib29","doi-asserted-by":"crossref","first-page":"842","DOI":"10.2174\/138945012800564095","article-title":"Adenosine deaminase in the modulation of immune system and its potential as a novel target for treatment of inflammatory disorders","volume":"13","author":"Antonioli","year":"2012","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.coph.2023.102393_bib30","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.ejphar.2010.10.041","article-title":"Differential recruitment of high affinity A1 and A2A adenosine receptors in the control of colonic neuromuscular function in experimental colitis","volume":"650","author":"Antonioli","year":"2011","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.coph.2023.102393_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2017.06.005","article-title":"Switching off CD73: a way to boost the activity of conventional and targeted antineoplastic therapies","volume":"22","author":"Antonioli","year":"2017","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.coph.2023.102393_bib32","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/01.MIB.0000198535.13822.a9","article-title":"A2a receptors mediate inhibitory effects of adenosine on colonic motility in the presence of experimental colitis","volume":"12","author":"Antonioli","year":"2006","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.coph.2023.102393_bib33","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.molcel.2013.03.016","article-title":"Extracellular adenosine sensing-a metabolic cell death priming mechanism downstream of p53","volume":"50","author":"Long","year":"2013","journal-title":"Mol Cell"},{"key":"10.1016\/j.coph.2023.102393_bib34","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.pharmthera.2008.08.010","article-title":"Regulation of enteric functions by adenosine: pathophysiological and pharmacological implications","volume":"120","author":"Antonioli","year":"2008","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.coph.2023.102393_bib35","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s00424-003-1103-2","article-title":"The equilibrative nucleoside transporter family, SLC29","volume":"447","author":"Baldwin","year":"2004","journal-title":"Pfl\u00fcgers Archiv"},{"key":"10.1016\/j.coph.2023.102393_bib36","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/pros.21438","article-title":"Adenosine induces cell-cycle arrest and apoptosis in androgen-dependent and -independent prostate cancer cell lines, LNcap-FGC-10, DU-145, and PC3","volume":"72","author":"Aghaei","year":"2012","journal-title":"Prostate"},{"key":"10.1016\/j.coph.2023.102393_bib37","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/j.bcp.2007.01.020","article-title":"Intracellularly transported adenosine induces apoptosis in HuH-7 human hepatoma cells by downregulating c-FLIP expression causing caspase-3\/-8 activation","volume":"73","author":"Yang","year":"2007","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.coph.2023.102393_bib38","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1002\/jcb.24048","article-title":"A(2a) adenosine receptor mediates HepG2 cell apoptosis by downregulating Bcl-X(L) expression and upregulating Bid expression","volume":"113","author":"Tamura","year":"2012","journal-title":"J\u00a0Cell Biochem"},{"key":"10.1016\/j.coph.2023.102393_bib39","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.canlet.2009.10.016","article-title":"Tuning of apoptosis-mediator gene transcription in HepG2 human hepatoma cells through an adenosine signal","volume":"291","author":"Yang","year":"2010","journal-title":"Cancer Lett"},{"key":"10.1016\/j.coph.2023.102393_bib40","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1002\/1097-0142(19930801)72:3+<962::AID-CNCR2820721303>3.0.CO;2-H","article-title":"The molecular biology of carcinogenesis","volume":"72","author":"Pitot","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.coph.2023.102393_bib41","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1002\/jcp.21863","article-title":"Cl-IB-MECA enhances TRAIL-induced apoptosis via the modulation of NF-kappaB signalling pathway in thyroid cancer cells","volume":"221","author":"Morello","year":"2009","journal-title":"J\u00a0Cell Physiol"},{"key":"10.1016\/j.coph.2023.102393_bib42","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000339048","article-title":"AMP converted from intracellularly transported adenosine upregulates p53 expression to induce malignant pleural mesothelioma cell apoptosis","volume":"30","author":"Nogi","year":"2012","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.coph.2023.102393_bib43","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000325203","article-title":"AMID mediates adenosine-induced caspase-independent HuH-7 cell apoptosis","volume":"27","author":"Yang","year":"2011","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.coph.2023.102393_bib44","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.pharmthera.2013.04.002","article-title":"The role of purinergic pathways in the pathophysiology of gut diseases: pharmacological modulation and potential therapeutic applications","volume":"139","author":"Antonioli","year":"2013","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.coph.2023.102393_bib45","first-page":"527","article-title":"Inhibition of T cell and natural killer cell function by adenosine and its contribution to immune evasion by tumor cells","volume":"32","author":"Hoskin","year":"2008","journal-title":"Int J Oncol"},{"key":"10.1016\/j.coph.2023.102393_bib46","series-title":"StatPearls","article-title":"Acute myocardial infarction","author":"Mechanic","year":"2020"},{"key":"10.1016\/j.coph.2023.102393_bib47","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s11897-017-0343-y","article-title":"From inflammation to fibrosis-molecular and cellular mechanisms of myocardial tissue remodelling and perspectives on differential treatment opportunities","volume":"14","author":"Suthahar","year":"2017","journal-title":"Curr Heart Fail Rep"},{"key":"10.1016\/j.coph.2023.102393_sref48","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9020204","article-title":"Role of adenosine and purinergic receptors in myocardial infarction: focus on different signal transduction pathways","volume":"9","author":"Procopio","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.coph.2023.102393_bib49","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/BF02912880","article-title":"Antioxidant status in patients with acute myocardial infarction","volume":"22","author":"Patil","year":"2007","journal-title":"Indian J Clin Biochem"},{"key":"10.1016\/j.coph.2023.102393_bib50","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/S0735-1097(99)00418-0","article-title":"Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction: results of a multicenter, randomized, placebo-controlled trial: the Acute Myocardial Infarction STudy of ADenosine (AMISTAD) trial","volume":"34","author":"Mahaffey","year":"1999","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.coph.2023.102393_bib51","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/j.jacc.2005.02.061","article-title":"A\u00a0randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II)","volume":"45","author":"Ross","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.coph.2023.102393_bib52","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ijcard.2015.09.005","article-title":"Clinical benefit of adenosine as an adjunct to reperfusion in ST-elevation myocardial infarction patients: an updated meta-analysis of randomized controlled trials","volume":"202","author":"Bulluck","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.coph.2023.102393_bib53","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1161\/ATVBAHA.111.226845","article-title":"Regulation of neutrophil function by adenosine","volume":"32","author":"Barletta","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.coph.2023.102393_bib54","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.ijcard.2014.09.203","article-title":"Intracoronary injection of adenosine before reperfusion in patients with ST-segment elevation myocardial infarction: a randomized controlled clinical trial","volume":"177","author":"Garcia-Dorado","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.coph.2023.102393_bib55","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1093\/eurheartj\/ehw136","article-title":"Strategies to attenuate micro-vascular obstruction during P-PCI: the randomized reperfusion facilitated by local adjunctive therapy in ST-elevation myocardial infarction trial","volume":"37","author":"Nazir","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.coph.2023.102393_sref56","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1124\/jpet.111.191288","article-title":"GS-6201, a selective blocker of the A2B adenosine receptor, attenuates cardiac remodeling after acute myocardial infarction in the mouse","volume":"343","author":"Toldo","year":"2012","journal-title":"J\u00a0Pharmacol Exp Therapeut"},{"key":"10.1016\/j.coph.2023.102393_bib57","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.hrthm.2013.10.023","article-title":"Blockade of A2B adenosine receptor reduces left ventricular dysfunction and ventricular arrhythmias 1 week after myocardial infarction in the rat model","volume":"11","author":"Zhang","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.coph.2023.102393_bib58","doi-asserted-by":"crossref","first-page":"553","DOI":"10.2147\/DDDT.S113289","article-title":"Adenosine A2A receptor agonist prevents cardiac remodeling and dysfunction in spontaneously hypertensive male rats after myocardial infarction","volume":"11","author":"da Silva","year":"2017","journal-title":"Drug Des Dev Ther"},{"key":"10.1016\/j.coph.2023.102393_bib59","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1083\/jcb.201412052","article-title":"Recent insights into the cellular biology of atherosclerosis","volume":"209","author":"Tabas","year":"2015","journal-title":"J\u00a0Cell Biol"},{"key":"10.1016\/j.coph.2023.102393_bib60","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1016\/S0140-6736(18)31668-4","article-title":"Mortality due to low-quality health systems in the universal health coverage era: a systematic analysis of amenable deaths in 137 countries","volume":"392","author":"Kruk","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.coph.2023.102393_bib61","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1161\/CIRCULATIONAHA.106.676890","article-title":"Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications","volume":"116","author":"Tabas","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.coph.2023.102393_sref62","article-title":"NLRP3 inflammasome: a potential alternative therapy target for atherosclerosis","volume":"2020","author":"Liu","year":"2020","journal-title":"Evid Based Complement Alternat Med"},{"key":"10.1016\/j.coph.2023.102393_bib63","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1161\/ATVBAHA.106.137851","article-title":"Topological determinants and consequences of adventitial responses to arterial wall injury","volume":"27","author":"Michel","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.coph.2023.102393_sref64","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1161\/CIRCRESAHA.107.158147","article-title":"Adenosine receptor-mediated adhesion of endothelial progenitors to cardiac microvascular endothelial cells","volume":"102","author":"Ryzhov","year":"2008","journal-title":"Circ Res"},{"key":"10.1016\/j.coph.2023.102393_bib65","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25204652","article-title":"Therapeutic perspectives of adenosine deaminase inhibition in cardiovascular diseases","volume":"25","author":"Kutryb-Zajac","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.coph.2023.102393_bib66","article-title":"Correlation between low adenosine A2A receptor expression and hypercholesterolemia: a new component of the cardiovascular risk?","volume":"1866","author":"Vairo","year":"2021","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"10.1016\/j.coph.2023.102393_bib67","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1586\/ecp.12.8","article-title":"Targeting adenosine receptors in the development of cardiovascular therapeutics","volume":"5","author":"Riksen","year":"2012","journal-title":"Expet Rev Clin Pharmacol"},{"key":"10.1016\/j.coph.2023.102393_bib68","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1172\/JCI27933","article-title":"The A2B adenosine receptor protects against inflammation and excessive vascular adhesion","volume":"116","author":"Yang","year":"2006","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.coph.2023.102393_bib69","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.bbalip.2012.11.005","article-title":"Adenosine A(2A) receptor activation supports an atheroprotective cholesterol balance in human macrophages and endothelial cells","volume":"1831","author":"Voloshyna","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.coph.2023.102393_bib70","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s10753-010-9288-y","article-title":"Cholesterol 27-hydroxylase but not apolipoprotein apoE contributes to A2A adenosine receptor stimulated reverse cholesterol transport","volume":"35","author":"Bingham","year":"2012","journal-title":"Inflammation"},{"key":"10.1016\/j.coph.2023.102393_bib71","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0008-6363(96)00140-X","article-title":"Role of adenosine in the heart and circulation","volume":"32","author":"Mubagwa","year":"1996","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.coph.2023.102393_bib72","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1161\/HYPERTENSIONAHA.117.10765","article-title":"Adenosine receptors influence hypertension in dahl salt-sensitive rats: dependence on receptor subtype, salt diet, and sex","volume":"72","author":"Jackson","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.coph.2023.102393_bib73","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1097\/00005344-199305000-00020","article-title":"Cardiovascular and renal effects of blocking A1 adenosine receptors","volume":"21","author":"Kuan","year":"1993","journal-title":"J\u00a0Cardiovasc Pharmacol"},{"key":"10.1016\/j.coph.2023.102393_bib74","doi-asserted-by":"crossref","first-page":"H719","DOI":"10.1152\/ajpheart.00593.2006","article-title":"Evidence for the involvement of nitric oxide in A2B receptor-mediated vasorelaxation of mouse aorta","volume":"292","author":"Ansari","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.coph.2023.102393_bib75","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/FJC.0b013e318278575e","article-title":"Functional and RNA expression profile of adenosine receptor subtypes in mouse mesenteric arteries","volume":"61","author":"Teng","year":"2013","journal-title":"J\u00a0Cardiovasc Pharmacol"},{"key":"10.1016\/j.coph.2023.102393_sref76","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1113\/jphysiol.2013.265835","article-title":"Pre-exposure to adenosine, acting via A(2A) receptors on endothelial cells, alters the protein kinase A dependence of adenosine-induced dilation in skeletal muscle resistance arterioles","volume":"592","author":"Maimon","year":"2014","journal-title":"J\u00a0Physiol"},{"key":"10.1016\/j.coph.2023.102393_bib77","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1161\/01.HYP.33.1.511","article-title":"Effect of chronic salt loading on adenosine metabolism and receptor expression in renal cortex and medulla in rats","volume":"33","author":"Zou","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/j.coph.2023.102393_bib78","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1161\/01.HYP.0000039505.79741.15","article-title":"Effects of doxazosin and propranolol on A2A adenosine receptors in essential hypertension","volume":"40","author":"Varani","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.coph.2023.102393_bib79","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1161\/CIRCRESAHA.116.309726","article-title":"Purinergic signaling in the cardiovascular system","volume":"120","author":"Burnstock","year":"2017","journal-title":"Circ Res"},{"key":"10.1016\/j.coph.2023.102393_bib80","doi-asserted-by":"crossref","first-page":"F1166","DOI":"10.1152\/ajprenal.00222.2012","article-title":"Renal afferent arteriolar and tubuloglomerular feedback reactivity in mice with conditional deletions of adenosine 1 receptors","volume":"303","author":"Li","year":"2012","journal-title":"Am J Physiol Ren Physiol"},{"key":"10.1016\/j.coph.2023.102393_bib81","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/41771","article-title":"Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor","volume":"388","author":"Ledent","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.coph.2023.102393_bib82","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1096\/fj.11-200907","article-title":"The A2B adenosine receptor modulates pulmonary hypertension associated with interstitial lung disease","volume":"26","author":"Karmouty-Quintana","year":"2012","journal-title":"Faseb J"},{"key":"10.1016\/j.coph.2023.102393_bib83","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/978-3-540-89615-9_6","article-title":"Adenosine receptors and the heart: role in regulation of coronary blood flow and cardiac electrophysiology","author":"Mustafa","year":"2009","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.coph.2023.102393_bib84","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1139\/y95-220","article-title":"ATP shortens atrial action potential duration in the dog: role of adenosine, the vagus nerve, and G protein","volume":"74","author":"Pelleg","year":"1996","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.coph.2023.102393_bib85","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1006\/jmcc.1997.0585","article-title":"Myocardial function in the working mouse heart overexpressing cardiac A1 adenosine receptors","volume":"30","author":"Gauthier","year":"1998","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.coph.2023.102393_bib86","doi-asserted-by":"crossref","first-page":"H2789","DOI":"10.1152\/ajpheart.2001.280.6.H2789","article-title":"Selective attenuation by adenosine of arrhythmogenic action of isoproterenol on ventricular myocytes","volume":"280","author":"Song","year":"2001","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.coph.2023.102393_bib87","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/00045391-200203000-00008","article-title":"Proarrhythmic effects of adenosine: one decade of clinical data","volume":"9","author":"Pelleg","year":"2002","journal-title":"Am J Therapeut"},{"key":"10.1016\/j.coph.2023.102393_sref88","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s11302-018-9636-1","article-title":"Adenosine plasma level in patients with paroxysmal or persistent atrial fibrillation and normal heart during ablation procedure and\/or cardioversion","volume":"15","author":"Maille","year":"2019","journal-title":"Purinergic Signal"},{"key":"10.1016\/j.coph.2023.102393_sref89","first-page":"22","article-title":"Adenosine A2A receptors are upregulated in peripheral blood mononuclear cells from atrial fibrillation patients","author":"Godoy-Marin","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"Suppl 1","key":"10.1016\/j.coph.2023.102393_bib90","first-page":"S1","article-title":"Advances in the management of heart failure","volume":"45","author":"Fonarow","year":"2022","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.coph.2023.102393_bib91","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.746494","article-title":"Inflammation in human heart failure: major mediators and therapeutic targets","volume":"12","author":"Reina-Couto","year":"2021","journal-title":"Front Physiol"},{"key":"10.1016\/j.coph.2023.102393_bib92","series-title":"Proceedings of the National Academy of Sciences of U S A","first-page":"6541","article-title":"Transgenic A1 adenosine receptor overexpression increases myocardial resistance to ischemia","volume":"94","author":"Matherne","year":"1997"},{"key":"10.1016\/j.coph.2023.102393_bib93","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1096\/fj.02-0543fje","article-title":"Changes of peripheral A2A adenosine receptors in chronic heart failure and cardiac transplantation","volume":"17","author":"Varani","year":"2003","journal-title":"Faseb J"},{"key":"10.1016\/j.coph.2023.102393_sref94","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.3390\/ijms16022732","article-title":"The association of ADORA2A and ADORA2B polymorphisms with the risk and severity of chronic heart failure: a case-control study of a northern Chinese population","volume":"16","author":"Zhai","year":"2015","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.coph.2023.102393_bib95","doi-asserted-by":"crossref","first-page":"e874","DOI":"10.1097\/CCM.0000000000003252","article-title":"Adenosine plasma level and A2A receptor expression in patients with cardiogenic shock","volume":"46","author":"Gaubert","year":"2018","journal-title":"Crit Care Med"},{"key":"10.1016\/j.coph.2023.102393_bib96","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1161\/CIRCULATIONAHA.108.788307","article-title":"Adenosine A3 receptor deficiency exerts unanticipated protective effects on the pressure-overloaded left ventricle","volume":"118","author":"Lu","year":"2008","journal-title":"Circulation"}],"container-title":["Current Opinion in Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489223000486?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489223000486?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T06:57:32Z","timestamp":1761461852000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471489223000486"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":96,"alternative-id":["S1471489223000486"],"URL":"https:\/\/doi.org\/10.1016\/j.coph.2023.102393","relation":{},"ISSN":["1471-4892"],"issn-type":[{"value":"1471-4892","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adenosine signaling as target in cardiovascular pharmacology","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coph.2023.102393","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102393"}}